Status:
ACTIVE_NOT_RECRUITING
Formula Diet Treatment for NASH Patients.
Lead Sponsor:
West German Center of Diabetes and Health
Conditions:
Steatohepatitis, Nonalcoholic
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the r...
Detailed Description
Outpatients with NASH will be included into this lifestyle intervention study. Patients will get nutritional advices and a formula diet for 12 weeks. Clinical visits will take place at baseline, after...
Eligibility Criteria
Inclusion
- BMI\>25 kg/qm
Exclusion
- history of drug or alcohol abuse
- acute or chronic diseases (except type 2 diabetes)
- pregnancy or breast feeding
Key Trial Info
Start Date :
January 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04707651
Start Date
January 18 2021
End Date
March 31 2025
Last Update
July 11 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Düsseldorf Catholic Hospital Group
Düsseldorf, Germany, 40591
2
Praxis Prof. Erhardt
Wuppertal, Germany, 42283